• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

426
71
48
47
24

COUNTRY

46
17
5
5
5

PRICE

292
545
1,162
1,447

PUBLISHED

7
115
481
1,447

PRODUCT TYPE

1,349
67
18
13

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE

Trigeminal Neuralgia - Pipeline Review, H2 2014

Trigeminal Neuralgia - Pipeline Review, H2 2014 Summary This, ‘Trigeminal Neuralgia - Pipeline Review, H2 2014’, provides an overview of the Trigeminal Neuralgia’s therapeutic pipeline. This report...

December 2014
FROM

Muscle Spasticity - Pipeline Review, H2 2014

Muscle Spasticity - Pipeline Review, H2 2014 Summary This, ‘Muscle Spasticity - Pipeline Review, H2 2014’, provides an overview of the Muscle Spasticity’s therapeutic pipeline. This report provides...

December 2014
FROM

Western Equine Encephalitis - Pipeline Review, H2 2014

Western Equine Encephalitis - Pipeline Review, H2 2014 Summary This, ‘Western Equine Encephalitis - Pipeline Review, H2 2014’, provides an overview of the Western Equine Encephalitis’s therapeutic...

December 2014
FROM

Leukodystrophies - Pipeline Review, H2 2014

Leukodystrophies - Pipeline Review, H2 2014 Summary This, ‘Leukodystrophies - Pipeline Review, H2 2014’, provides an overview of the Leukodystrophies’s therapeutic pipeline. This report provides...

December 2014
FROM

Paralysis - Pipeline Review, H2 2014

Paralysis - Pipeline Review, H2 2014 Summary This, ‘Paralysis - Pipeline Review, H2 2014’, provides an overview of the Paralysis’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2014

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2014 Summary This, ‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2014’, provides an overview of the Primary...

December 2014
FROM

Tardive Dyskinesia - Pipeline Review, H2 2014

Tardive Dyskinesia - Pipeline Review, H2 2014 Summary This, ‘Tardive Dyskinesia - Pipeline Review, H2 2014’, provides an overview of the Tardive Dyskinesia’s therapeutic pipeline. This report provides...

December 2014
FROM

Lennox-Gastaut Syndrome - Pipeline Review, H2 2014

Lennox-Gastaut Syndrome - Pipeline Review, H2 2014 Summary This, ‘Lennox-Gastaut Syndrome - Pipeline Review, H2 2014’, provides an overview of the Lennox-Gastaut Syndrome’s therapeutic pipeline. This...

December 2014
FROM

Status Epilepticus - Pipeline Review, H2 2014

Status Epilepticus - Pipeline Review, H2 2014 Summary This, ‘Status Epilepticus - Pipeline Review, H2 2014’, provides an overview of the Status Epilepticus’s therapeutic pipeline. This report provides...

December 2014
FROM

Nerve Injury - Pipeline Review, H2 2014

Nerve Injury - Pipeline Review, H2 2014 Summary This, ‘Nerve Injury - Pipeline Review, H2 2014’, provides an overview of the Nerve Injury’s therapeutic pipeline. This report provides comprehensive...

December 2014
FROM

Age Related Memory Impairment - Pipeline Review, H2 2014

Age Related Memory Impairment - Pipeline Review, H2 2014 Summary This, ‘Age Related Memory Impairment - Pipeline Review, H2 2014’, provides an overview of the Age Related Memory Impairment’s therapeutic...

December 2014
FROM

Hyperalgesia - Pipeline Review, H2 2014

Hyperalgesia - Pipeline Review, H2 2014 Summary This, ‘Hyperalgesia - Pipeline Review, H2 2014’, provides an overview of the Hyperalgesia’s therapeutic pipeline. This report provides comprehensive...

December 2014
FROM

Peripheral Neuropathic Pain - Pipeline Review, H2 2014

Peripheral Neuropathic Pain - Pipeline Review, H2 2014 Summary This, ‘Peripheral Neuropathic Pain - Pipeline Review, H2 2014’, provides an overview of the Peripheral Neuropathic Pain’s therapeutic...

December 2014
FROM

Japanese Encephalitis - Pipeline Review, H2 2014

Japanese Encephalitis - Pipeline Review, H2 2014 Summary This, ‘Japanese Encephalitis - Pipeline Review, H2 2014’, provides an overview of the Japanese Encephalitis’s therapeutic pipeline. This report...

December 2014
FROM

Brain Injury - Pipeline Review, H2 2014

Brain Injury - Pipeline Review, H2 2014 Summary This, ‘Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Brain Injury’s therapeutic pipeline. This report provides comprehensive...

December 2014
FROM

Tauopathies - Pipeline Review, H2 2014

Tauopathies - Pipeline Review, H2 2014 Summary This, ‘Tauopathies - Pipeline Review, H2 2014’, provides an overview of the Tauopathies’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Post-Operative Pain - Pipeline Review, H2 2014

Post-Operative Pain - Pipeline Review, H2 2014 Summary This, ‘Post-Operative Pain - Pipeline Review, H2 2014’, provides an overview of the Post-Operative Pain’s therapeutic pipeline. This report...

November 2014
FROM

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2014

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2014 Summary This, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2014’, provides...

November 2014
FROM

Seizures - Pipeline Review, H2 2014

Seizures - Pipeline Review, H2 2014 Summary This, ‘Seizures - Pipeline Review, H2 2014’, provides an overview of the Seizures’s therapeutic pipeline. This report provides comprehensive information...

November 2014
FROM

Nicotine Addiction - Pipeline Review, H2 2014

Nicotine Addiction - Pipeline Review, H2 2014 Summary This, ‘Nicotine Addiction - Pipeline Review, H2 2014’, provides an overview of the Nicotine Addiction’s therapeutic pipeline. This report provides...

November 2014
FROM
Loading Indicator

Our Clients

Shire PLC. GlaxoSmithKline PLC Astrazeneca PLC Roche Diagnostics Ltd. H. Lundbeck A/S Electrical Geodesics, Inc.